 |
市场调查报告书
商品编码
1629180
糖尿病胃轻瘫市场，按类型、治疗、配销通路、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测Diabetic Gastroparesis Market, By Types, By Treatment, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032 |
||||||
价格
简介目录
报告要点
2023年，糖尿病胃轻瘫市场规模为19.749亿美元，2024年至2032年复合年增长率为4.30%。
糖尿病胃轻瘫市场-市场动态
糖尿病盛行率上升导致市场需求激增
不断增加的糖尿病病例正在推动市场需求，国际糖尿病联合会报告称，截至2021年，全球糖尿病病例已达5.37亿。扩大了相关治疗的市场。然而，糖尿病患者对胃轻瘫的认识有限，限制了早期诊断和治疗，影响了市场成长。相反，胃轻瘫药物疗法的不断创新为全球糖尿病胃轻瘫市场的成长提供了充满希望的机会。此外，全球老年人口的不断增加增加了对有效胃轻瘫治疗的需求，尤其是老年糖尿病患者。
糖尿病胃轻瘫市场 - 主要见解
根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.30% 左右的复合年增长率成长
根据类型细分，预计 3 级将在 2023 年显示最大的市场份额
从治疗细分来看，2023年药物治疗是主导细分
按地区划分，北美是 2023 年的主要收入来源
糖尿病胃轻瘫市场-細項分析：
全球糖尿病胃轻瘫市场根据类型、治疗、配销通路和地区进行细分。
市场依类型分为两类：3级（胃衰竭）和2级（代偿性胃轻瘫）。 3 级（胃衰竭）领域主导市场。这种情况的严重性需要更强化的治疗和管理方案，这推动了市场的更高需求。
市场根据治疗分为两类：手术治疗和药物治疗。药物治疗领域在市场中占据主导地位，并可能在预测期内保持其主导地位。与手术相比，它提供了侵入性较小的选择，并包括一系列可有效控制症状的药物，如促动力剂和止吐剂。
糖尿病胃轻瘫市场-地理洞察
从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。
糖尿病胃轻瘫市场-竞争格局：
由于糖尿病病例的增加和对有针对性的治疗方案的需求，全球市场正在扩大。公司正致力于开发有效解决胃轻瘫症状的创新疗法，同时改善药物配方以提高患者的依从性。策略合作、临床试验和研发投资是将新疗法推向市场的核心策略，而一些公司则探索区域合作伙伴关係，以改善新兴市场的准入并优化分销网络。
最新进展：
2024 年 6 月，Renexxion Ireland Limited 获得 FDA 批准那罗那必利的研究新药 (IND) 申请，那罗那必利是一种旨在治疗胃轻瘫的口服药物。这种有前景的药物旨在解决与胃排空缓慢相关的症状，例如噁心和呕吐，从而推进胃肠道疾病的治疗选择。
目录
第 1 章：糖尿病胃轻瘫市场概述
- 研究范围
- 市场预估年份
第 2 章：执行摘要
- 市场片段
- 按类型分類的糖尿病胃轻瘫市场片段
- 糖尿病胃轻瘫治疗市场片段
- 按配销通路分類的糖尿病胃轻瘫市场片段
- 按国家/地区分類的糖尿病胃轻瘫市场片段
- 按地区分類的糖尿病胃轻瘫市场片段
- 竞争洞察
第 3 章：糖尿病胃轻瘫主要市场趋势
- 糖尿病胃轻瘫市场驱动因素
- 市场驱动因素的影响分析
- 糖尿病胃轻瘫市场限制
- 市场限制影响分析
- 糖尿病胃轻瘫市场机会
- 糖尿病胃轻瘫市场未来趋势
第 4 章：糖尿病胃轻瘫产业研究
- PEST分析
- 波特五力分析
- 成长前景图
- 规范架构分析
第 5 章：糖尿病胃轻瘫市场：地缘政治紧张局势升级的影响
- COVID-19 大流行的影响
- 俄罗斯-乌克兰战争的影响
- 中东衝突的影响
第 6 章：糖尿病胃轻瘫市场格局
- 2023 年糖尿病胃轻瘫市场占有率分析
- 按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析
第 7 章：糖尿病胃轻瘫市场 - 按类型
- 概述
- 按类型分類的细分市场占有率分析
- 3 级（胃衰竭）
- 2级（代偿性胃轻瘫）
第 8 章：糖尿病胃轻瘫市场 - 依治疗分类
- 概述
- 按处理方式分類的细分市场占有率分析
- 手术
- 药物治疗
- 止吐剂
- 促动力
- 肉毒桿菌
- 其他的
第 9 章：糖尿病胃轻瘫市场 - 按配销通路
- 概述
- 按配销通路分類的细分市场份额分析
- 网路药局
- 零售药局
- 医院药房
第 10 章：糖尿病胃轻瘫市场 - 依地理位置
- 介绍
- 按地理位置分類的细分市场占有率分析
- 北美洲
- 概述
- 北美糖尿病胃轻瘫主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按类型）
- 北美市场规模与预测（以不同处理方式）
- 北美市场规模和预测（按配销通路）
- 我们
- 加拿大
- 欧洲
- 概述
- 欧洲糖尿病胃轻瘫主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按类型）
- 欧洲市场规模与预测（按处理方式）
- 欧洲市场规模和预测（按配销通路）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
- 亚太地区 (APAC)
- 概述
- 亚太地区糖尿病胃轻瘫主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按类型）
- 亚太地区市场规模与预测（以不同处理方式）
- 亚太地区市场规模和预测（按配销通路）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
- 拉丁美洲
- 概述
- 拉丁美洲糖尿病胃轻瘫主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按类型）
- 拉丁美洲市场规模与预测（以不同处理方式）
- 拉丁美洲市场规模和预测（按配销通路）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
- 中东和非洲
- 概述
- 中东和非洲糖尿病胃轻瘫主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按类型）
- 中东及非洲市场规模及预测（依不同处理方式）
- 中东和非洲市场规模及预测（按配销通路）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分
第 11 章：主要供应商分析-糖尿病胃轻瘫产业
- 竞争仪表板
- Competitive Benchmarking
- Competitive Positioning
- 公司简介
- Theravance Biopharma
- Allergan
- Abbott
- AstraZeneca
- Evoke Pharma
- Cadila Pharmaceuticals
- Neurogastrx, Inc.
- Eli Lilly and Company
- Bausch Health
- Teva Pharmaceutical Industries Ltd.
- Alfa Wassermann SPA
- Takeda Pharmaceutical Company Limited
- Boston Scientific Corporation
- Cardinal Health, Inc.
- CR Bard, Inc.
- Halyard Health, Inc.
- Kimberly-Clark Corporation
- Janssen Global Services, LLC
- Medtronic
- Rhythm Pharmaceuticals, Inc.
- Others
第 12 章：360 度分析师视角
第 13 章：附录
- 研究方法
- 参考
- 缩写
- 免责声明
- 联络我们
简介目录
Product Code: ANV4440
REPORT HIGHLIGHT
Diabetic gastroparesis market size was valued at USD 1,974.90 Million in 2023, expanding at a CAGR of 4.30% from 2024 to 2032.
Diabetic Gastroparesis is a digestive disorder where diabetes damages the vagus nerve, slowing stomach muscle function. This impairs stomach emptying, causing food to remain longer than normal, leading to symptoms like nausea, bloating, vomiting, and fluctuating blood sugar levels. It is common in individuals with long-term or poorly controlled diabetes, particularly type 1. Managing it involves dietary adjustments, blood sugar control, and, in some cases, medications or other therapies.
Diabetic Gastroparesis Market- Market Dynamics
Rising prevalence of diabetes to surge the market demand
The increasing number of diabetes cases is driving market demand, with International Diabetes federation reporting 537 million global diabetes cases as of 2021. Besides, an aging population and lifestyle changes contribute to more diabetes and gastroparesis cases, expanding the market for related treatments. However, limited awareness among diabetic patients about gastroparesis restricts early diagnosis and treatment, affecting market growth. On the contrary, continuous innovation in gastroparesis drug therapies offers promising opportunities for the global diabetic gastroparesis market growth. Furthermore, the rising geriatric population worldwide increases the demand for effective gastroparesis treatments, especially for elderly diabetes patients.
Diabetic Gastroparesis Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2024-2032)
Based on types segmentation, grade 3 was predicted to show maximum market share in the year 2023
Based on treatment segmentation, pharmacological treatment was the leading segment in 2023
On the basis of region, North America was the leading revenue generator in 2023
Diabetic Gastroparesis Market- Segmentation Analysis:
The Global Diabetic Gastroparesis Market is segmented on the basis of Types, Treatment, Distribution Channel, and Region.
The market is divided into two categories based on types: grade 3 (gastric failure) and grade 2 (compensated gastroparesis). The grade 3 (gastric failure) sector dominates the market. The severe nature of this condition, which demands more intensive treatment and management options is driving higher demand in the market.
The market is divided into two categories based on treatment: surgery and pharmacological treatment. The pharmacological treatment sector dominates the market and is likely to maintain its dominance during the forecast period. It offers less invasive options compared to surgery and includes a range of drugs like prokinetics and antiemetics, which are effective in symptom management.
Diabetic Gastroparesis Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Diabetic Gastroparesis Market- Competitive Landscape:
The global market is expanding due to rising cases of diabetes and the demand for targeted treatment options. Companies are focusing on developing innovative therapies that address gastroparesis symptoms effectively, alongside improving drug formulations to enhance patient adherence. Strategic collaborations, clinical trials, and R&D investments are core strategies employed to bring novel treatments to market, while some companies explore regional partnerships to improve access in emerging markets and optimize distribution networks.
Recent Developments:
In June 2024, Renexxion Ireland Limited received FDA approval for an Investigational New Drug (IND) application for naronapride, an oral medication designed to treat gastroparesis. This promising drug aims to address symptoms associated with slow gastric emptying, such as nausea and vomiting, advancing treatment options for gastrointestinal disorders.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIABETIC GASTROPARESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Theravance Biopharma
- Allergan
- Abbott
- AstraZeneca
- Evoke Pharma
- Cadila Pharmaceuticals
- Neurogastrx, Inc.
- Eli Lilly and Company
- Bausch Health
- Teva Pharmaceutical Industries Ltd.
- Alfa Wassermann SPA
- Takeda Pharmaceutical Company Limited
- Boston Scientific Corporation
- Cardinal Health, Inc.
- C. R. Bard, Inc.
- Halyard Health, Inc.
- Kimberly-Clark Corporation
- Janssen Global Services, LLC
- Medtronic
- Rhythm Pharmaceuticals, Inc.
- Others
GLOBAL DIABETIC GASTROPARESIS MARKET, BY TYPES- MARKET ANALYSIS, 2019 - 2032
- Grade 3 (Gastric Failure)
- Grade 2 (Compensated Gastroparesis)
GLOBAL DIABETIC GASTROPARESIS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032
- Surgical
- Pharmacological Treatment
- Antiemetic Agents
- Prokinetics
- Botulinum
- Others
GLOBAL DIABETIC GASTROPARESIS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
GLOBAL DIABETIC GASTROPARESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Diabetic Gastroparesis Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Diabetic Gastroparesis Market Snippet by Types
- 2.1.2. Diabetic Gastroparesis Market Snippet by Treatment
- 2.1.3. Diabetic Gastroparesis Market Snippet by Distribution Channel
- 2.1.4. Diabetic Gastroparesis Market Snippet by Country
- 2.1.5. Diabetic Gastroparesis Market Snippet by Region
- 2.2. Competitive Insights
3. Diabetic Gastroparesis Key Market Trends
- 3.1. Diabetic Gastroparesis Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Diabetic Gastroparesis Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Diabetic Gastroparesis Market Opportunities
- 3.4. Diabetic Gastroparesis Market Future Trends
4. Diabetic Gastroparesis Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Diabetic Gastroparesis Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Diabetic Gastroparesis Market Landscape
- 6.1. Diabetic Gastroparesis Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Diabetic Gastroparesis Market - By Types
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Types, 2023 & 2032 (%)
- 7.1.2. Grade 3 (Gastric Failure)
- 7.1.3. Grade 2 ( Compensated Gastroparesis)
8. Diabetic Gastroparesis Market - By Treatment
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 8.1.2. Surgery
- 8.1.3. Pharmacological Treatment
- 8.1.3.1. Antiemetic Agents
- 8.1.3.2. Prokinetics
- 8.1.3.3. Botulinum
- 8.1.3.4. Others
9. Diabetic Gastroparesis Market - By Distribution Channel
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 9.1.2. Online Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Hospital Pharmacies
10. Diabetic Gastroparesis Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Diabetic Gastroparesis Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Diabetic Gastroparesis Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Diabetic Gastroparesis Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Diabetic Gastroparesis Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Diabetic Gastroparesis Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Types, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Diabetic Gastroparesis Industry
- 11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
- 11.2. Company Profiles
- 11.2.1. Theravance Biopharma
- 11.2.2. Allergan
- 11.2.3. Abbott
- 11.2.4. AstraZeneca
- 11.2.5. Evoke Pharma
- 11.2.6. Cadila Pharmaceuticals
- 11.2.7. Neurogastrx, Inc.
- 11.2.8. Eli Lilly and Company
- 11.2.9. Bausch Health
- 11.2.10. Teva Pharmaceutical Industries Ltd.
- 11.2.11. Alfa Wassermann SPA
- 11.2.12. Takeda Pharmaceutical Company Limited
- 11.2.13. Boston Scientific Corporation
- 11.2.14. Cardinal Health, Inc.
- 11.2.15. C. R. Bard, Inc.
- 11.2.16. Halyard Health, Inc.
- 11.2.17. Kimberly-Clark Corporation
- 11.2.18. Janssen Global Services, LLC
- 11.2.19. Medtronic
- 11.2.20. Rhythm Pharmaceuticals, Inc.
- 11.2.21. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
